Business Description
IntelliPharmaCeutics International Inc
NAICS : 325412
SIC : 3741
ISIN : CA4581731011
Compare
Compare
Traded in other countries / regions
IPCI.H.CanadaI4AA.GermanyIPCIF.USA IPO Date
2013-11-22Description
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | 23.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 11.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IntelliPharmaCeutics International Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.838 | ||
| EPS (TTM) (€) | -0.086 | ||
| Beta | 2.92 | ||
| Volatility % | 60.54 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.0445 | ||
| 12-1 Month Momentum % | 23.61 | ||
| 52-Week Range (€) | 0.0345 - 0.076 | ||
| Shares Outstanding (Mil) | 33.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IntelliPharmaCeutics International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IntelliPharmaCeutics International Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
IntelliPharmaCeutics International Inc Frequently Asked Questions
What is IntelliPharmaCeutics International Inc(FRA:I4AA)'s stock price today?
The current price of FRA:I4AA is €0.04. The 52 week high of FRA:I4AA is €0.08 and 52 week low is €0.03.
When is next earnings date of IntelliPharmaCeutics International Inc(FRA:I4AA)?
The next earnings date of IntelliPharmaCeutics International Inc(FRA:I4AA) is .
Does IntelliPharmaCeutics International Inc(FRA:I4AA) pay dividends? If so, how much?
IntelliPharmaCeutics International Inc(FRA:I4AA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers